BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MYH11, ENSG00000133392, 4629 AND Clinical Outcome
9 results:

  • 1. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemia.
    Yu T; Chi J; Wang L
    Hematology; 2021 Dec; 26(1):848-859. PubMed ID: 34674615
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
    Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidence and Prognostic Value of Known Genetic Aberrations in Patients with Acute Myeloid leukemia--a Two Year Study.
    Vaskova J; Dubayova K; Cakanova G; Luckova I; Bochova I; Novotna G; Sabo J; Palasthy S; Tothova E; Stecova N; Karabinos A
    Klin Onkol; 2015; 28(4):278-83. PubMed ID: 26299742
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia.
    Shen Y; Zhu YM; Fan X; Shi JY; Wang QR; Yan XJ; Gu ZH; Wang YY; Chen B; Jiang CL; Yan H; Chen FF; Chen HM; Chen Z; Jin J; Chen SJ
    Blood; 2011 Nov; 118(20):5593-603. PubMed ID: 21881046
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. WT1 monitoring in core binding factor AML: comparison with specific chimeric products.
    Lasa A; Carricondo M; Estivill C; Bussaglia E; Gich I; Brunet S; Aventin A; Sierra J; Nomdedéu JF
    Leuk Res; 2009 Dec; 33(12):1643-9. PubMed ID: 19427034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
    Mrózek K; Bloomfield CD
    J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
    Marcucci G; Caligiuri MA; Bloomfield CD
    Eur J Haematol; 2003 Sep; 71(3):143-54. PubMed ID: 12930314
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Quantification of CBFbeta/myh11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.